Mysterious silence? Last I heard they were suggesting that shareholders will soon hold nothing. As for the buyout predictions, I have seen those on a daily basis for years.
Back to your DNDN dreaming/conspiracy theories. Meanwhile MDVN market value increases more in a day than DNDN's current total value. Let me know how this ends.
From The Street
Xtandi's data on delaying time to chemo is in the label. BIG win for $MDVN — David Miller (@AlpineBV_Miller) September 10, 2014
Xtandi label also has delay in time to skeletal-related events. $MDVN These are two label claims Zytiga does not have. — David Miller (@AlpineBV_Miller) September 10, 2014
The Xtandi pre-chemo survival data were presented at a medical meeting in January, and were pretty darn awesome.
A simple reply to your simple post. Xtandi was approved nearly two years ago and MDVN is still not showing a profit regardless of the price. The cost to find, test, go thru lenghty FDA approval (and have no guarantees youll ever get approved) produce and market a drug is staggering. If there is no hope of earning an eventual profit companies would simply stop experimenting. It makes for great press to claim the cost of a treatment is outrageous, until you use your brain and look at why. I for one hope companies continue to brave their own money is search of these wonder drugs.
The reopening in after hours seems to have taken the luster off this. It will be interesting to see if the market continues to yawn at this news during regular trading.
Lets see, created new ID in mid June and have over 600 postings, most of them only a sentence or two long. HMMMMM.
Thank you for your concern and wealth of knowledge. Once you grow up and start investing real money you will learn that stock prices typically reflect such information (although your generic Zytiga claim is false as is the just as effective claim, actually your whole post is wrong).
"101% owned by hedge fund insiders", wrong. Institutional ownership is high but they are not all hedge funds. As long as you DNDN followers continue to ignore reality and try and bend any news in your favor you will have a hard time making money. Spending more time interpreting your 10Q than worrying about MDVN holders would be a good start.
The people pumping DNDN do not have a very good track record. Place your bets where you wish and we will see who comes out ahead. Fantasy postings of $40 a share buyouts when your trading under $2 with threats of bankruptcy at your door? Good luck.
MDVN sales are rising rapidly and will son be cannibalizing the competitors (DNDN and JNJ) market share with its expanded approval.If your using its market cap to value DNDN your in for an expensive lesson. Your right that you won't be selling your shares, they have a high likelihood of becoming worthless.Unless a big company that wants the technology doesn't want to wait for a post bankruptcy buyout your on very thin ice.
Endless predictions of "news" and anyone who dares suggest otherwise is labeled a paid basher. No wonder these clowns are losing their shirts.
So in other words from their high DNDN was down 95% and is now only down 94%. MDVN was up 1100% and is now only up 1000%. Yeah I would say DNDN has the momentum.
Remember there is a big time difference with Japan. Depending on the time of day they release over there it could be available here on the 31st.